Franz X. Vollenweider

This study identifies DNA methylation changes in AUD patients after psilocybin treatment, finding significant CpG sites and methylation patterns linked to neuroplasticity and immune functions.

This study compares the effects of ketamine and psilocybin on sensory learning using EEG and computational modeling, finding distinct neural impacts on precision and volatility in auditory mismatch negativity.

This study investigates how ketamine induces distinct whole-brain functional connectivity patterns in individuals and links these patterns to gene expression and behavioral responses.

The paper shows spatial and temporal autocorrelation explain network topology measures in rs-fMRI data and how they change with aging and drug treatment.

The paper develops a stable brain-behavior space mapping for psychosis-spectrum disorders using symptom and brain data, showing univariate approaches outperform multivariate ones for individualized prediction.

The paper integrates transcriptomics with large-scale cortical modeling to simulate LSD's effects on brain function, revealing serotonin-2A receptor-mediated changes in cortical connectivity.

This study examines how psilocybin affects functional connectivity in mice, revealing distinct changes in serotonin and dopamine-related networks.

This study shows ketamine reduces high-level prediction errors in a roving MMN paradigm, supporting the role of NMDAR in hierarchical Bayesian inference.

This study shows that LSD-induced changes in brain connectivity are mediated by the 5-HT2A receptor, as demonstrated by the blocking effect of a 5-HT2A antagonist.